Search hospitals > Michigan > Chelsea
Saint Joseph Mercy Chelsea
Claim this profileChelsea, Michigan 48118
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
223 reported clinical trials
7 medical researchers
Summary
Saint Joseph Mercy Chelsea is a medical facility located in Chelsea, Michigan. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Saint Joseph Mercy Chelsea is involved with conducting 223 clinical trials across 357 conditions. There are 7 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Tareq Al BaghdadiSaint Joseph Mercy Hospital7 years of reported clinical research
Expert in Cancer
Expert in Tumors
69 reported clinical trials
127 drugs studied
Christopher M. Reynolds, MDSaint Joseph Mercy Hospital4 years of reported clinical research
Expert in Cancer
Studies Lung Cancer
45 reported clinical trials
99 drugs studied
Philip J. StellaSaint Joseph Mercy Hospital4 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
38 reported clinical trials
89 drugs studied
Elie G. DibSaint Joseph Mercy Hospital4 years of reported clinical research
Expert in Cancer
Studies Multiple Myeloma
34 reported clinical trials
94 drugs studied
Clinical Trials running at Saint Joseph Mercy Chelsea
Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Gastric Cancer
Prostate Cancer
Esophageal Cancer
Diffuse Large B-Cell Lymphoma
Gastroesophageal Junction Adenocarcinoma
Esophageal Adenocarcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Whole Brain Radiotherapy + Stereotactic Radiosurgery
for Brain Metastasis
This study is evaluating whether a combination of radiation therapy and memantine may be effective in treating cancer that has come back in the brain. original:
Recruiting2 awards Phase 312 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Saint Joseph Mercy Chelsea?
Saint Joseph Mercy Chelsea is a medical facility located in Chelsea, Michigan. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Saint Joseph Mercy Chelsea is involved with conducting 223 clinical trials across 357 conditions. There are 7 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.